· Depression prevalence rates for this rural community were greater than rates reported for the Canadian population. · The depression prevalence rate for the Aboriginal population was not greater than that for the non-Aboriginal population. · Not all patients with depression-anxiety disorders are prescribed antidepressants, and not everyone prescribed an antidepressant has a depression-anxiety disorder. · The higher suicide rates reported for First Nations people may be more closely related to something like binge-drinking behaviour than to higher depression rates in this population.
T he prevalence of depression in Canada is believed to be 4% to 6% (1) (2) (3) (4) . Key risk factors associated with the development of depression include being poor, unemployed, female, and unmarried (1, 4) . Age, physical disability, and cognitive impairment have also been associated with the development of depressive symptoms (5) .
Information on the prevalence of depression and related disorders among Aboriginal people living in Canada is practically nonexistent (6) (7) (8) . It is generally accepted that the depression rate for Aboriginal people is higher than the non-Aboriginal rate, if for no other reason than that a 2-to 6-times higher suicide rate is found among Aboriginal people in Canada, compared with the non-Aboriginal population (9) (10) (11) (12) .
Although published information exists regarding the prevalence of depression among rural residents, it is somewhat contradictory (1, 13) . In 1996 Parikh and colleagues reported no difference between rural and urban prevalence rates of depression in Ontario (1) . A rural-urban comparison of health indicators published by Statistics Canada in 2003 (13) found that people living in northern regions had high rates of depression, those living in rural regions adjacent to metropolitan regions had low rates of depression, and those living in remote rural regions had prevalence rates equivalent to those reported for Canada.
Reasons for these geographic discrepancies in depression prevalence rates have yet to be determined. Rural residents are generally known to be less healthy than their urban counterparts. Rural residents have higher rates of chronic disease; they report being ill more frequently; and they are more likely to report poorer health status (13, (14) (15) (16) (17) . Poorer health among rural residents has in turn been attributed to less education (14, 18) , lower income (14, 19) , and a greater proportion of First Nations people in this population (9, 20, 21) .
Prescription use of antidepressants is a health indicator that health care administrators monitor when they wish to assess whether people living in a community are receiving appropriate services (9) . The goals of these administrators include making sure that health services are allocated fairly and that health care resources are effectively used to optimize the health of the population. The prescription use of antidepressant medications presumably reflects the prevalence of depression-anxiety disorders in a population as well as the degree to which these medications have been chosen by physicians as part of the treatment plans. The provincial health officer for British Columbia reported that 12% of status Indian adults over age 25 years received a prescription for antidepressants in 2000. Comparable data for the nonAboriginal population were not available (9).
The main objectives of our study were to determine depression prevalence rates for Aboriginal and non-Aboriginal populations residing in a remote rural community and to determine the degree to which antidepressant medications were chosen by physicians as part of the treatment plans.
Methods
Bella Coola Valley is a geographically isolated community located in the central coast region of British Columbia (Figure 1 ). According to the 2001 British Columbia census, 2285 people lived in the Bella Coola Valley, and 46% of these people were of Aboriginal descent (22, 23) . Bella Coola Valley is part of the traditional territory of the Nuxalk Nation, which is a tribe of Salish-speaking Coastal Indians (24) (25) (26) (27) .
The United Church Health Medical Services operates a clinic and a hospital in Bella Coola together in the same site. There are no other primary care health facilities in this valley. Three salaried physicians service both the clinic and the hospital (28, 29) . The isolation of the community is such that almost everyone who lives in the Bella Coola Valley has either a clinic chart or an emergency department record, which makes it an ideal community in which to study population-based health issues.
We carried out this research project in a participatory fashion, following the recommendations outlined in a recently published policy statement entitled A Guide for Health Professionals Working With Aboriginal Peoples (6, 30, 31) . Prior to collecting data, we obtained letters of support from the Nuxalk Band Council, the Bella Coola Transitional Health Authority, and the Central Coast Regional District for a comprehensive study on a broad range of determinants of health for people living in the Bella Coola Valley. There were also community meetings where we explained the types of health projects we were doing and planning to do and answered public questions. We obtained approval to collect and summarize chart data from the research ethics committees located at the University of British Columbia and the University of Northern British Columbia. The results and the manuscript were reviewed and approved for publication by both Nuxalk health professionals and United Church Health Services health professionals.
A family physician who has worked in Bella Coola for over 15 years did 2 separate chart reviews. The antidepressant medications prescribed included tricyclic antidepressants (amitriptyline, clomipramine, desipramine, doxepin, imipramine, nortriptyline, and trimipramine), selective serotonin reuptake inhibitors (fluoxetine, fluvoxamine, paroxetine, sertraline, and citalopram), a reversible monoamine oxidase inhibitor (moclobemide), a norepinephrine and dopamine modulator (bupropion), serotonin antagonist and reuptake inhibitors (nefazodone and trazodone), and a serotonin norepinephrine reuptake inhibitor (venlafaxine).
Patients presenting to a family physician with affective depressive disorder, situation depression, anxiety disorder, a mixture of debilitating depressive-anxiety symptoms, or bipolar disorder were classified as suffering from a depression-anxiety disorder. Patients seen for relatively minor stress or anxiety symptoms alone were not classified as having a depression-anxiety disorder. Patients designated as having an anxiety disorder had to have a recognizable DSM-IV anxiety disorder diagnosis (for example, panic attack disorder, agoraphobia, obsessive-compulsive disorder, posttraumatic stress disorder, or generalized anxiety disorder). In this study, anxiety disorder does not include patients seen only once or twice who were said to be suffering from a few anxiety symptoms alone (29) .
In Canada, 3 groups of Aboriginal people are recognized: First Nations (formerly referred to as Indians), Métis, and Inuit (9, 12 We entered chart-derived information into an electronic spreadsheet from which results were summarized, graphs created, and the data sent to statisticians and other researchers for further analyses (36) . We analyzed the data using the Statistical Package for Social Sciences (SPSS) for Windows (37) . The main outcome measure was the percentage of the patient population who were given a prescription for the specified classes of drugs in 2001. We conducted Pearson chi-square (Asymp Sig [2-sided] ) and logistic regression analyses on the data to identify differences between male and female patients, between Aboriginal and non-Aboriginal people, and between increasing ages (38) .
Results
We identified 177 people living in the Bella Coola Valley as suffering from a depression-anxiety disorder in 2001. Of these, 110 (62%) clearly had a major affective depressive disorder; 11 (6%) had situational depression; 21 (12%) had an anxiety disorder; 32 (18%) had a mixture of debilitating depressive-anxiety symptoms; and 3 (2%) had bipolar disorder. Of the 177 people with a depression-anxiety disorder, 164 were over age 18 years, and antidepressants were prescribed for 136 of them. One-year prevalence rates are summarized in Tables 1 and 2 for the total Bella Coola Valley clinic population and for the adult (over age 18 years) clinic population.
With respect to antidepressant medications, 229 different antidepressant prescriptions were prescribed for 179 people (Table 3) Of the 179 people who were prescribed antidepressants, 136 were suffering from a depression-anxiety disorder. These 136 patients with a depression-anxiety disorder received · The rate for women was roughly double the rate for men.
· Proportionately more Aboriginal people, especially the women, were taking antidepressants. Pearson chi-square and logistic regression statistical analyses of the antidepressant prescription data revealed significant differences between male and female patients (P < 0.001) and with increasing age (P < 0.001); however, no significant differences appeared between Aboriginal and non-Aboriginal people (P = 0.942).
Discussion
The 1-year (2001) prevalence rate of depression-anxiety disorders for the Bella Coola Valley population was 7.5%. Excluding patients with obvious anxiety disorder and those with bipolar disorder results in a depression prevalence rate of about 6.4%, which is a little higher than previously reported Canadian prevalence rates of depression (1-4).
Approximately 77% of the people suffering from depressionanxiety disorders were prescribed antidepressants. Untreated patients included those who had less severe disease, those who refused to take antidepressant medications, those who received formal cognitive psychotherapy, and those who received less formal psychotherapy. Unfortunately, we did not quantify any of these groupings.
Interestingly, the number of people with depression-anxiety disorders who were not prescribed an antidepressant was almost identical to the number of people who were prescribed antidepressants for indications other than depression-anxiety, namely, chronic pain and insomnia. Tricyclics accounted for 29% (66/229) of the total antidepressant prescriptions, and SSRIs accounted for 51% (117/229) of the total, which is consistent with Canada-wide prescribing patterns for antidepressants (4,39).
According to our data for Bella Coola Valley, 11% of the Aboriginal population and 10.5% of the non-Aboriginal population over age 25 years received a prescription for antidepressants in 2001. The peak use of antidepressants occurred among Aboriginal women aged 45 to 64 years, with a prescription rate of 17.8% ( Figure 2) ; this rate is roughly the same as that reported for status Indian women of British Columbia (9) . Our finding that rates in male and female patients were lowest in the youngest and oldest age groups has been reported by others (4), as has our finding that women had higher rates of depression (1, 40) .
As previously mentioned, the provincial health officer for British Columbia reported that 12% of status Indian adults over age 25 years received a prescription for antidepressants in 2000 (9) . Health care planners and policy makers such as the provincial health officer should be aware of the limitations of using antidepressant prescription rates as a health indicator: not all patients with depression-anxiety disorders are being prescribed antidepressants, and not everyone prescribed an antidepressant has a depression-anxiety disorder.
Our data were subject to the limitations inherent in collecting medical chart information-especially, incomplete information and a lack of standardized diagnostic criteria. It was difficult to make precise DSM-IV diagnoses on the basis of the retrospective chart data provided. Some physicians wrote very short notes with little elaboration of the rationale behind the diagnosis of depression, whereas others diagnosed depression from Beck Depression Inventory scores. No one referred to DSM-IV criteria when making the diagnosis of depression, suggesting that this system does not adequately meet the needs of the primary care physicians working in this remote rural community. Last, it is possible that some Bella Coola Valley residents were suffering from depression-anxiety and were never seen by a family physician in 2001. A recent review of family physician visits to the Bella Coola Medical Clinic in 2001 revealed that 26% of the population did not see a family physician at all that year and that 15% of the population accounted for 52% of all visits (Thommasen and colleagues, unpublished).
Conclusion
The depression prevalence rate for the Bella Coola Valley population was 6.4%. The rates were similar for the Aboriginal and non-Aboriginal populations. Antidepressant medications were commonly prescribed to both Aboriginal and non-Aboriginal people. When using antidepressant medication prescriptions as a community health indicator, health care administrators should be aware that antidepressant medications are commonly prescribed for conditions other than depression-anxiety disorder. Conclusions : Les taux de prévalence des troubles dépressifs-anxieux chez les populations autochtones et non autochtones sont semblables. Les administrateurs des soins de santé qui utilisent les ordonnances d'antidépresseurs comme indicateur de la santé communautaire doivent savoir que les antidépresseurs sont souvent prescrits pour des affections autres que les troubles dépressifs-anxieux.
